Cognition Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:CGTX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities -6.85 M-8.38 M-9.88 M-5.62 M-5.65 M -29.53 M Cash from investing activities -58 K-30 K——— — Cash from financing activities 329 K11.38 M1.3 M752 K33.92 M 47.35 M Free cash flow -6.85 M-8.38 M-9.88 M-5.62 M-5.65 M -29.53 M

ニュース

コグニション・セラピューティクス、レビー小体型認知症薬についてFDAと会議

Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug

コグニション社のDLB治療薬、第2相試験で良好な結果を示す

Cognition’s DLB drug shows positive results in phase 2 trial

コグニション・セラピューティクス、拡大アクセスプログラムの登録完了

Cognition Therapeutics completes enrollment in expanded access program

コグニション・セラピューティクス、アルツハイマー病薬の第3相試験計画を発表

Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug

Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)

コグニション・セラピューティクス、アルツハイマー病薬の治験登録完了

Cognition Therapeutics completes enrollment in Alzheimer’s drug trial

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?